Trials / Completed
CompletedNCT03674853
The Study of Wuling Capsule in Treatment Chronic Tinnitus
Clinical Study of Wuling Capsule in the Treatment of Chronic Tinnitus With Emotional Disorder
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 59 (actual)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life.
Detailed description
To evaluate the effect of psychological/mental factors on the severity of subjective tinnitus, to observe the efficacy and safety of Wuling capsule in the treatment of chronic subjective tinnitus with emotional disorders, and to evaluate the control rate of tinnitus complications, such as depression, anxiety and insomnia, and the improvement of patients'quality of life. Patients with chronic tinnitus complicated with mild to moderate anxiety or depression were randomly divided into two groups. The experimental group was given oral treatment with Wuling capsule, and the control group was given gurusu treatment. The improvement of tinnitus, sleep, anxiety and depression in patients was evaluated at 2,4 and 8 weeks after treatment, respectively, and the efficacy of Wuling capsule in improving tinnitus combined with anxiety, depression and tinnitus was analyzed。
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Wuling Capsule | take Wuling Capsule in experiment group for 2 months |
| DRUG | Oryzanol | take oryzanol in active comparator group for 2 months |
Timeline
- Start date
- 2018-06-12
- Primary completion
- 2019-10-30
- Completion
- 2020-03-30
- First posted
- 2018-09-18
- Last updated
- 2022-07-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03674853. Inclusion in this directory is not an endorsement.